The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Animated patient’s guide to lung cancer enables shared decisions and improves health outcomes.
 
Manish Patel
Consulting or Advisory Role - Nektar
Research Funding - AstraZeneca; Fate Therapeutics; Merck KGaA; Vyriad
 
Shanda H. Blackmon
No Relationships to Disclose
 
Arkadiusz Z. Dudek
Leadership - IGF Oncology; Martell diagnostic; Squarex Pharma; TTC Oncology
Stock and Other Ownership Interests - IGF Oncology; Martell diagnostic; Squarex Pharma; TTC Oncology
Patents, Royalties, Other Intellectual Property - IGF Oncology
 
Naomi Fujioka
Consulting or Advisory Role - AstraZeneca (Inst)
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
 
Shirley Kern
No Relationships to Disclose
 
Nancy Torrison
No Relationships to Disclose
 
Pasi A. Janne
Stock and Other Ownership Interests - Gatekeeper Pharmaceuticals; Loxo
Consulting or Advisory Role - Araxes Pharma; AstraZeneca; Bayer; Biocartis; Biocartis; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Eisai; Ignyta; Lilly; LOXO; Merrimack; Mirati Therapeutics; Novartis; Nuvalent, Inc.; Pfizer; Roche/Genentech; Sanofi; SFJ Pharmaceuticals Group; Silicon Therapeutics; Takeda; Voronoi Health Analytics
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly; Puma Biotechnology; Revolution Medicines; Takeda
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a DFCI owned patent on EGFR mutations licensed to Lab Corp. I receive post-marketing royalties from this invention